title: Bifidobacteria-host interactions--an update on colonisation factors.
abstract: Bifidobacteria are one of the predominant bacterial groups of the human intestinal microbiota and have important functional properties making them interesting for the food and dairy industries. Numerous in vitro and preclinical studies have shown beneficial effects of particular bifidobacterial strains or strain combinations on various health parameters of their hosts. This indicates the potential of bifidobacteria in alternative or supplementary therapeutic approaches in a number of diseased states. Based on these observations, bifidobacteria have attracted considerable interest by the food, dairy, and pharmaceutical industries and they are widely used as so-called probiotics. As a consequence of the rapidly increasing number of available bifidobacterial genome sequences and their analysis, there has been substantial progress in the identification of bifidobacterial structures involved in colonisation of and interaction with the host. With the present review, we aim to provide an update on the current knowledge on the mechanisms by which bifidobacteria colonise their hosts and exert health promoting effects.
authors.affiliation: Institute of Microbiology and Biotechnology, University of Ulm, 89068 Ulm, Germany.
authors.forename: Verena
authors.initials: V
authors.lastname: Grimm
authors.affiliation: Institute of Microbiology and Biotechnology, University of Ulm, 89068 Ulm, Germany.
authors.forename: Christina
authors.initials: C
authors.lastname: Westermann
authors.affiliation: Institute of Microbiology and Biotechnology, University of Ulm, 89068 Ulm, Germany.
authors.forename: Christian U
authors.initials: CU
authors.lastname: Riedel
mesh_terms: D001644:Bifidobacterium / Q000235:genetics* / Q000254:growth & development* / Q000378:metabolism; D041981:Gastrointestinal Tract / Q000382:microbiology; D054884:Host-Pathogen Interactions / Q000235:genetics; D006801:Humans; D064307:Microbiota / Q000235:genetics; D019936:Probiotics / Q000627:therapeutic use*